Claus Sundgreen

Claus Sundgreen has worked as a Medical Director since 2000, beginning their career with Nycomed. Claus then moved on to Schering Plough in 2005 and NeuroSearch in 2011, where they held the role of Vice President Clinical Development and Medical Director, respectively. In 2013, they became Chief Medical Officer at Sundgreen Consulting. Claus then took on roles as Medical and Safety Consultant at RSPR Pharma and Medical Director and Medical Consultant at Orphazyme A/S in 2014 and 2015, respectively. In 2021, they began working as a Consultant Medical Director for VectorY, and in 2022 they took on the same role for Abcuro, Inc and TIKOMED AB.

Claus Sundgreen completed their MD in Medicine at Københavns Universitet - University of Copenhagen from 1983 to 1990. Claus then obtained a Diploma in Pharmaceutical Medicine from Karolinska Institutet in 2003-2004. In addition, they hold certifications in Basic and Advanced GCP from Brookwood Global and a Diploma in Pharmaceutical Medicine from Karolinska Instituttet. Prior to this, they attended Vordingborg Gymnasium from 1980 to 1983.